Bridgeway Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-19,900
Closed -$5.74M – 1408
2023
Q2
$5.74M Buy
19,900
+13,800
+226% +$4.19M 0.14% 245
2023
Q1
$1.95M Buy
+6,100
New +$1.81M 0.05% 534
2020
Q4
– Sell
-8,100
Closed -$1.92M – 1360
2020
Q3
$1.92M Sell
8,100
-9,780
-55% -$2.06M 0.04% 439
2020
Q2
$3.47M Sell
17,880
-10,170
-36% -$1.94M 0.07% 260
2020
Q1
$4.65M Hold
28,050
– – 0.11% 162
2019
Q4
$4.8M Buy
28,050
+1,350
+5% +$225K 0.06% 260
2019
Q3
$4.4M Buy
+26,700
New +$3.75M 0.06% 254

Other funds holding PODD

Bridgeway Capital Management's PODD Position: Q3 2023 in Review

Bridgeway Capital Management sold out of Insulet (PODD) in Q3 2023, closing a stake of 19,900 shares — an estimated $5.74M sold.

Bridgeway Capital Management first reported a position in PODD in Q3 2019 and held it in 7 quarters. The position peaked at $5.74M in Q2 2023. 528 funds tracked by Wall St. Rank hold PODD as of Q3 2023.

  • Bridgeway Capital Management reported no remaining Insulet position as of Q3 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 19,900 Insulet shares in Q3 2023, an estimated $5.74M.
  • Bridgeway Capital Management first reported a position in Insulet in Q3 2019 and held it in 7 quarters.
  • Bridgeway Capital Management's Insulet position peaked at $5.74M in Q2 2023.
  • 528 funds tracked by Wall St. Rank held Insulet as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.